ETR
65
4
NEE
44
3
NFLX
74
4
FRT
39
3
EIX
62
3
NTAP
60
2
DHR
40
5
RHI
50
2
CRM
67
2
R
61
2
ZBH
71
3
ADI
59
2
HOG
29
2
YUM
43
3
TRIP
66
2
FE
37
3
PFE
33
-2
DTE
54
5
KIM
60
3
EA
44
3
ETR
65
4
NEE
44
3
NFLX
74
4
FRT
39
3
EIX
62
3
NTAP
60
2
DHR
40
5
RHI
50
2
CRM
67
2
R
61
2
ZBH
71
3
ADI
59
2
HOG
29
2
YUM
43
3
TRIP
66
2
FE
37
3
PFE
33
-2
DTE
54
5
KIM
60
3
EA
44
3
Financhill
Back

Milestone Pharmaceuticals Vs. NovoCure Industry Stock Comparison

Sell
46

MIST
Milestone Pharmaceuticals

Last Price:
$1.86
Seasonality Move:
-17.08%
Sell
49

NVCR
NovoCure

Last Price:
$30.93
Seasonality Move:
-8.57%
Sell
46
Milestone Pharmaceuticals (MIST) is a Sell

Is Milestone Pharmaceuticals a Buy, Sell or Hold?

  • The current Milestone Pharmaceuticals [MIST] share price is $1.85. The Score for MIST is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
  • MIST is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
49
NovoCure (NVCR) is a Sell

Is NovoCure a Buy, Sell or Hold?

  • The current NovoCure [NVCR] share price is $30.97. The Score for NVCR is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • NVCR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

MIST Stock Price Chart

What is Milestone Pharmaceuticals's stock price today?

  • The Milestone Pharmaceuticals share price today is $1.85
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MIST is experiencing buying pressure, which is a positive indicator for future bullish movement.

NVCR Stock Price Chart

What is NovoCure's stock price today?

  • The NovoCure share price today is $30.97
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NVCR is experiencing buying pressure, which is a positive indicator for future bullish movement.

MIST Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.01 Buy
Relative Strength Index (14 RSI): 54.63 Buy
Chaikin Money Flow: 77693 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.77 - 1.91) Buy
Bollinger Bands (100): (1.4 - 1.78) Buy

NVCR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 3.02 Buy
Relative Strength Index (14 RSI): 64.15 Buy
Chaikin Money Flow: 291530 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (20.5 - 32.28) Buy
Bollinger Bands (100): (14.36 - 24.58) Buy

MIST Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.79 Buy
20-day SMA: 1.85 Buy
50-day SMA: 1.72 Buy
200-day SMA: 1.58 Buy
8-day EMA: 1.81 Buy
20-day EMA: 1.81 Buy
50-day EMA: 1.74 Buy
200-day EMA: 1.75 Buy

NVCR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 31.43 Sell
20-day SMA: 28.64 Buy
50-day SMA: 21.62 Buy
200-day SMA: 18.41 Buy
8-day EMA: 30.72 Buy
20-day EMA: 28.28 Buy
50-day EMA: 23.76 Buy
200-day EMA: 20.64 Buy

Milestone Pharmaceuticals Earnings Growth & MIST Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.77 per share, and a decrease next year of $0.20 per share.

NovoCure Earnings Growth & NVCR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.71 per share, and a decrease next year of $0.31 per share.

Milestone Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

NovoCure Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):